Cowen Downgrades Complete Genomic (GNOM) to Neutral
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Price: $58.31 -1.27%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cowen downgraded Complete Genomic (NASDAQ: GNOM) from Outperform to Neutral.
For more ratings news on Complete Genomic click here and for the rating history of Complete Genomic click here.
Shares of Complete Genomic closed at $17.11 yesterday.
For more ratings news on Complete Genomic click here and for the rating history of Complete Genomic click here.
Shares of Complete Genomic closed at $17.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Axis Capital Limited Downgrades Tata Motors Passenger Vehicles (TMPV:IN) to Sell (4)
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
